Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

The plight of the general surgeon: an analysis of urgent and emergent surgeries at a community hospital.

Karr CJ, Kilbourne SN, Cameron CN, Adams A, Clancy TV, Hope WW.

Am Surg. 2015 Apr;81(4):176-8. No abstract available.

PMID:
25831171
2.

The effect of watchful waiting on the management and treatment of inguinal hernias in a community setting.

Williams ZF, Mulrath A, Adams A, Hooks WB, Hope WW.

Am Surg. 2015 Mar;81(3):300-4.

PMID:
25760208
3.

Pharmacodynamics of Amphotericin B Deoxycholate, Amphotericin B Lipid Complex, and Liposomal Amphotericin B against Aspergillus fumigatus.

Al-Nakeeb Z, Petraitis V, Goodwin J, Petraitiene R, Walsh TJ, Hope WW.

Antimicrob Agents Chemother. 2015 May;59(5):2735-45. doi: 10.1128/AAC.04723-14. Epub 2015 Feb 23.

PMID:
25712363
4.

Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development.

Abdul-Aziz MH, Lipman J, Mouton JW, Hope WW, Roberts JA.

Semin Respir Crit Care Med. 2015 Feb;36(1):136-53. doi: 10.1055/s-0034-1398490. Epub 2015 Feb 2.

PMID:
25643277
5.

Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients.

Roberts JA, Udy AA, Jarrett P, Wallis SC, Hope WW, Sharma R, Kirkpatrick CM, Kruger PS, Roberts MS, Lipman J.

J Antimicrob Chemother. 2015 May;70(5):1495-502. doi: 10.1093/jac/dku564. Epub 2015 Jan 20.

PMID:
25608584
6.

Comparison of the accuracy and precision of pharmacokinetic equations to predict free meropenem concentrations in critically ill patients.

Wong G, Farkas A, Sussman R, Daroczi G, Hope WW, Lipman J, Roberts JA.

Antimicrob Agents Chemother. 2015 Mar;59(3):1411-7. doi: 10.1128/AAC.04001-14. Epub 2014 Dec 15.

PMID:
25512414
7.

The effect of temporal artery biopsy on the treatment of temporal arteritis.

Le K, Bools LM, Lynn AB, Clancy TV, Hooks WB 3rd, Hope WW.

Am J Surg. 2015 Feb;209(2):338-41. doi: 10.1016/j.amjsurg.2014.07.007. Epub 2014 Oct 13.

PMID:
25457237
8.

Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents.

Hope WW, Kaibara A, Roy M, Arrieta A, Azie N, Kovanda LL, Benjamin DK Jr.

Antimicrob Agents Chemother. 2015 Feb;59(2):905-13. doi: 10.1128/AAC.03736-14. Epub 2014 Nov 24.

9.

Population pharmacokinetics of teicoplanin in children.

Ramos-Martín V, Paulus S, Siner S, Scott E, Padmore K, Newland P, Drew RJ, Felton TW, Docobo-Pérez F, Pizer B, Pea F, Peak M, Turner MA, Beresford MW, Hope WW.

Antimicrob Agents Chemother. 2014 Nov;58(11):6920-7. doi: 10.1128/AAC.03685-14. Epub 2014 Sep 15.

PMID:
25224001
10.

First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazole.

Zhao W, Le Guellec C, Benjamin DK Jr, Hope WW, Bourgeois T, Watt KM, van den Anker JN, Matrot B, Saxen H, Hoppu K, Manzoni P, Jacqz-Aigrain E.

Clin Pharmacokinet. 2014 Nov;53(11):1005-18. doi: 10.1007/s40262-014-0169-7.

PMID:
25154507
11.

How severe is antibiotic pharmacokinetic variability in critically ill patients and what can be done about it?

Felton TW, Hope WW, Roberts JA.

Diagn Microbiol Infect Dis. 2014 Aug;79(4):441-7. doi: 10.1016/j.diagmicrobio.2014.04.007. Epub 2014 Apr 30. Review.

PMID:
24985764
12.

Pulmonary penetration of piperacillin and tazobactam in critically ill patients.

Felton TW, McCalman K, Malagon I, Isalska B, Whalley S, Goodwin J, Bentley AM, Hope WW.

Clin Pharmacol Ther. 2014 Oct;96(4):438-48. doi: 10.1038/clpt.2014.131. Epub 2014 Jun 13.

PMID:
24926779
13.

Evaluating informed consent obtained by surgical residents.

Hope WW, Walters K, Bools LM, Adams A, Hooks WB 3rd, Clancy TV.

Am Surg. 2014 May;80(5):522-4. No abstract available.

PMID:
24887738
14.

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.

Felton TW, Roberts JA, Lodise TP, Van Guilder M, Boselli E, Neely MN, Hope WW.

Antimicrob Agents Chemother. 2014 Jul;58(7):4094-102. doi: 10.1128/AAC.02664-14. Epub 2014 May 5.

15.

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.

Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL; International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases.

Lancet Infect Dis. 2014 Jun;14(6):498-509. doi: 10.1016/S1473-3099(14)70036-2. Epub 2014 Apr 24. Review.

PMID:
24768475
16.

Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW.

Drug Resist Updat. 2013 Dec;16(6):81-95. doi: 10.1016/j.drup.2014.01.001. Epub 2014 Jan 27. Review.

PMID:
24618110
17.

An invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistance.

Gomez-Lopez A, Forastiero A, Cendejas-Bueno E, Gregson L, Mellado E, Howard SJ, Livermore JL, Hope WW, Cuenca-Estrella M.

Med Mycol. 2014 Apr;52(3):311-9. doi: 10.1093/mmy/myt022. Epub 2014 Feb 4.

PMID:
24577012
18.

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.

Chowdhary A, Meis JF, Guarro J, de Hoog GS, Kathuria S, Arendrup MC, Arikan-Akdagli S, Akova M, Boekhout T, Caira M, Guinea J, Chakrabarti A, Dannaoui E, van Diepeningen A, Freiberger T, Groll AH, Hope WW, Johnson E, Lackner M, Lagrou K, Lanternier F, Lass-Flörl C, Lortholary O, Meletiadis J, Muñoz P, Pagano L, Petrikkos G, Richardson MD, Roilides E, Skiada A, Tortorano AM, Ullmann AJ, Verweij PE, Cornely OA, Cuenca-Estrella M; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology.

Clin Microbiol Infect. 2014 Apr;20 Suppl 3:47-75. doi: 10.1111/1469-0691.12515.

19.

Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days.

Livermore J, Howard SJ, Sharp AD, Goodwin J, Gregson L, Felton T, Schwartz JA, Walker C, Moser B, Müller W, Harrison TS, Perfect JR, Hope WW.

MBio. 2014 Jan 28;5(1):e00725-13. doi: 10.1128/mBio.00725-13.

20.

Changes in the incidence of candidiasis in neonatal intensive care units.

Aliaga S, Clark RH, Laughon M, Walsh TJ, Hope WW, Benjamin DK, Kaufman D, Arrieta A, Benjamin DK Jr, Smith PB.

Pediatrics. 2014 Feb;133(2):236-42. doi: 10.1542/peds.2013-0671. Epub 2014 Jan 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk